A new research article by Dr Frank Oertel and colleagues has just been published
in the JCTS on the results from 51 patients (mean age 67 years) implanted with the
BioIntegral Surgical MitroFix Mitral valve restoration system between 2006 and 2011
at 3 centres in Europe. Results show that the MitroFix is effective at treating MR
and offers several advantages over conventional annuloplasty techniques.